Sponsored Content
Sotagliflozin’s Effect on BP Remains in T2D Regardless of Kidney Function | AHA 2024
Research presented at American Heart Association’s 2024 Scientific Sessions examined the SGLT inhibitor’s effect on systolic blood pressure.
Episode 6: High Risk: Diabetes and COVID-19
In this episode of Over the Counter, 2 experts on diabetes management and care discuss the effect COVID-19 is having on individuals with diabetes and the ways that the health care system is responding.
Eating Problems, Diabetes Distress Associated with Worse Time-in-Range | AHA 2024
Patients with type 2 diabetes who had eating problems and higher levels of diabetes distress had worse time-in-range.
Pharmacist-Led CGM Workflow Could Help Improve Diabetes Outcomes
A study found that a continuous glucose monitor workflow led by a pharmacist led to reduced HbA1c levels.
Greater Depression Severity Linked with Increased Diabetes Risk
A recent study found that with greater depression severity, metabolic and clinical characteristics such as HbA1c, fasting blood glucose, and triglyceride levels increased.
Q&A: Key Things Pharmacists Need to Know About Insulin Icodec
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses a recent meta-analysis that evaluated the efficacy, safety, and clinical implications of insulin icodec.
